Society for Immunotherapy of Cancer (SITC)
Alicia Schuessler is a seasoned professional with extensive experience in non-profit and association management within the medical and scientific communities. Currently serving as the Associate Executive Director and Director of Education at the Society for Immunotherapy of Cancer since July 2016, Alicia previously held the position of Associate Executive Director for both the American Society of Gene & Cell Therapy and the American Venous Forum from June 2014 to July 2016. Alicia's career also includes significant roles at the Society of Behavioral Medicine, where responsibilities ranged from Director of Administration to Senior Communications and Membership Manager, as well as positions at the National Anemia Action Council and Fun Services, Inc. Alicia earned a Bachelor of Science degree in Brain, Behavior and Cognitive Science from the University of Michigan in 2007.
This person is not in any teams
Society for Immunotherapy of Cancer (SITC)
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. sitc_log_color.png Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Currently, SITC has more than 2,000 members who represent 22 medical specialties in 42 countries around the world. Through emphasis on high-caliber scientific meetings; dedication to education and outreach activities; focus on initiatives of major importance in the field; and commitment to collaborations with like-minded domestic and international organizations, government and regulatory agencies, associations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.